Fast itch relief in an experimental model for methylprednisolone aceponate topical corticosteroid activity, based on allergic contact eczema to nickel sulphate

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 10, 2014, Pages 1356-1362

  Curto, L ^a   Carnero, Ll ^a   Lopez Aventin D ^a   Traveria, G ^b   Roura, G ^b   Gimenez Arnau A M ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b ADKNOMA Health Research SL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE ACEPONATE; NICKEL SULFATE; ANTIINFLAMMATORY AGENT; IRRITANT AGENT; METHYLPREDNISOLONE; NICKEL; OINTMENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORIMETRY; CONTACT DERMATITIS; CORTICOSTEROID THERAPY; DRUG EFFECT; ERYTHEMA; HUMAN; INTERVENTION STUDY; MORPHOMETRICS; OINTMENT; PATCH TEST; PHASE 1 CLINICAL TRIAL; PRURITUS; SINGLE BLIND PROCEDURE; SKIN SENSITIZATION; TOPICAL TREATMENT; TREATMENT RESPONSE; VISUAL ANALOG SCALE; ADOLESCENT; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS, ALLERGIC CONTACT; FEMALE; FOLLOW UP; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TIME; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; YOUNG ADULT;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; DERMATITIS, ALLERGIC CONTACT; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRRITANTS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; NICKEL; OINTMENTS; PATCH TESTS; SINGLE-BLIND METHOD; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84908115718     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12292     Document Type: Article

References (29)

1. Kimber I, Basketter DA, Gerberick GF, Dearman RJ,. Allergic contact dermatitis. Int Immunopharmacol 2002; 2: 201-211.
2. Kimber I, Maxwell G, Gilmour N, et al,. Allergic contact dermatitis: a commentary on the relationship between T lymphocytes and skin sensitising potency. Toxicology 2012; 291: 18-24.
3. Thyssen J, Linneberg A, Menné T, Johansen JD,. The epidemiology of contact allergy in the general population-prevalence and main findings. Contact Dermatitis 2007; 57: 287-299.
4. Nelson JL, Mowad CM,. Allergic contact dermatitis. J Clin Aesthet Dermatol 2010; 3: 36-41.
5. Jackson EM,. The biostatiscal significance of panel size in patch testing. Am J Contact Dermat 1994; 5: 228-230.
6. Chrostowska-Plak D, Salomon J, Reich A, Szpietowski JC,. Clinical aspects of itch in adult atopic dermatitis patients. Acta Derm Venereol 2009; 89: 379-383.
7. Dawn A, Papoiu AD, Chan YH, et al,. Itch characteristics in atopic dermatitis: results of a web-based questionnaire. Br J Dermatol 2009; 160: 642-644.
8. Reich A, Chrostowska-Plak D, Szpietowski JC,. The influence of itching on atopic dermatitis patients' well-being. Acta Derm Venereol 2007; 87: 471-472.
9. Warschburger P, Buchholz HT, Petermann F,. Psychological adjustment in parents of young children with atopic dermatitis: which factors predict parental quality of life? Br J Dermatol 2004; 150: 304-306.
10. Weisshaar E, Apfelbacher CJ, Jäger G, et al,. Pruritus as a leading symptom-clinical characteristics and quality of life in German and Ugandan patients. Br J Dermatol 2006; 155: 957-964.
11. Weisshaar E, Diepgen TL, Bruckner T, et al,. Itch intensity evaluated in the German atopic dermatitis intervention study (GADIS): correlation with quality of life, coping behavior and SCORAD severity in 823 children. Acta Derm Venereol 2008; 88: 234-239.
12. Ebata T, Iwaski S, Kamide R, Niimura M,. Use of a wrist activity monitor for the measurement of nocturnal scratching in patients with atopic dermatitis. Br J Dermatol 2001; 114: 305-309.
13. Benjamin K, Waterston K, Russell M, et al,. The development of an objective method for measuring scratch in children with atopic dermatitis suitable for clinical use. J Am Acad Dermatol 2004; 50: 33-40.
14. Yosipovitch G, Goon AT, Wee J, et al,. Itch characteristics in Chinese patients with atopic dermatitis using a new questionnaire for the assessment of pruritus. Int J Dermatol 2002; 41: 212-216.
15. Ayala F, Nino M, Fabbrocini G, et al,. Quality of life and contact dermatitis: a disease -specific questionnaire. Dermatitis 2010; 21: 84-90.
16. Hoare C, Li Wan Po A, Williams HC,. Systematic review of treatments for atopic eczema. Health Technol Assess 2000; 4: 25-28.
17. Thomas KS, Armstrong S, Avery A, et al,. Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. BMJ 2002; 324: 768.
18. Luger TA,. Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponate. J Eur Acad Dermatol Venereol 2010; 25: 251-258.
19. Ruzicka T,. Methylprednisolone aceponate in eczema and other inflammatory skin disorders-a clinical update. Int J Clin Pract 2006; 60: 85-92.
20. Bieber T, Vick K, Fölster-Holst R, et al,. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. Allergy 2007; 62: 184-189.
21. Szczepanowska J, Reich A, Szepietowski JC,. Emmollients improve treatment results with topical corticosteroids in childhoodatopic dermatitis: a randomized comparative study. Pediatr Allergy Immunol 2008; 19: 614-618.
22. Elmariah SB, Lerner EA,. Topical therapies for pruritus. Semin Cutan Med Surg 2011; 30: 118-126.
23. Kircik LH,. Efficacy and onset of action of hydrocortisone acetate 2.5% and pramoxine hydrochloride 1% lotion for the management of pruritus. Results of a pilot study. J Clin Aesthet Dermatol 2011; 4: 48-50.
24. Phan NQ, Blome C, Fritz F, et al,. Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venereol 2012; 92: 502-507.
25. Reich A, Heisig M, Phan NQ, et al,. Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol 2012; 92: 297-501.
26. Furue M, Ebata T, Ikoma A, et al,. Verbalizing extremes of the visual analogue scale for pruritus: a consensus statement. Acta Derm Venereol 2013; 93: 214-215.
27. Westphal GA, Schnuch A, Moessner R, et al,. Cytokine gene polymorphisms in allergic contact dermatitis. Contact Dermatitis 2003; 48: 93-98.
28. Schram SE, Warshaw EM,. Genetics of nickel allergic contact dermatitis. Dermatitis 2007; 18: 125-133.
29. Schnuch A, Westphal G, Mössner R, et al,. Genetic factors in contact allergy -review and future goals. Contact Dermatitis 2011; 64: 2-23.